Received: 3 August 2019
Accepted: 9 October 2019
First Online: 21 November 2019
Compliance with ethical standards
: The authors have no conflict of interest to disclose.
: Giuseppe Querques has the following disclosures: ALLERGAN (S), ALIMERA (S), AMGEN (S), BAYER (S), KHB (S), NOVARTIS (S), ROCHE (S), SANDOZ (S), ZEISS (C,S); ALLERGAN (C), ALIMERA (C), BAUSCH AND LOMB (C), BAYER (C), HEIDELBERG (C), NOVARTIS (C), ZEISS (C). Francesco Bandello has the following disclosures: ALLERGAN (S), ALIMERA (S), BAYER (S), FARMILA-THEA (S), SCHERING PHARMA (S), SANOFI-AVENTIS (S), NOVAGALI (S), PHARMA (S), HOFFMANN-LA ROCHE (S), GENETECH (S), NOVARTIS (S). Mariacristina Parravano has the following disclosures: Allergan (S), Bayer (S); Novartis (S).
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
: Informed consent was obtained from all patients for being included in the study.